Autres langues Generation Bio Co.

Actions

GBIO

US37148K1007

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 26/04/2024			Varia. 5j.	Varia. 1 janv.
2,9 ^USD	-3,65%		+3,57%	+75,76%

12/04	Transcript : Generation Bio Co. - Special Call
07/03	GENERATION BIO CO. : Needham & Co. reste à l'achat	ZM

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting	22/04
Generation Bio to Present at the 23rd Annual Needham Virtual Healthcare Conference	02/04
Generation Bio Co. Reports Earnings Results for the Full Year Ended December 31, 2023	06/03
Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results	06/03
Generation Bio Co. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	06/03
Generation Bio to Present at the 2024 TD Cowen Health Care Conference	27/02
Generation Bio to Present at the 2024 TD Cowen Health Care Conference	27/02
Generation Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference	03/01
Generation Bio Co.(NasdaqGS:GBIO) dropped from NASDAQ Biotechnology Index	15/12
Generation Bio Insider Bought Shares Worth $124,778, According to a Recent SEC Filing	05/12
Generation Bio to Lay Off 40% of Staff in Bid to Extend Cash Runway Into H2 2027	29/11
Generation Bio Co. Announces Termination of Executives, Effective on January 28, 2024	29/11
Generation Bio Announces Strategic Reorganization to Extend Cash Runway for Development of ctLNP and iqDNA Platforms	29/11
Generation Bio Announces Strategic Reorganization to Extend Cash Runway for Development of ctLNP and iqDNA Platforms	29/11
Generation Bio Co. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11
Generation Bio Reports Business Highlights and Third Quarter 2023 Financial Results	09/11
Generation Bio Announces Demonstration of Highly Selective T Cell Transduction In Vivo with Cell-Targeted LNP Platform	26/10/23
Generation Bio Announces Demonstration of Highly Selective T Cell Transduction In Vivo with Cell-Targeted LNP Platform	26/10/23
Generation Bio Co. Announces Demonstration of Highly Selective T Cell Transduction in Vivo with Cell-Targeted Lnp Platform	26/10/23
North American Morning Briefing : Yields Fall -2-	24/10/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Generation Bio Co.

Actions

GBIO

US37148K1007

Autres langues

Filtres